查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032415

馬匹保健市場：按產品、適應症、分銷管道和地區分類（2026-2034 年）

Equine Healthcare Market by Product, Indication, Distribution Channel, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球馬匹保健市場規模達17億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到27億美元，2026年至2034年的複合年成長率為5.10%。馬匹數量的快速成長、飼主對馬匹健康和合理營養意識的提高以及先進診斷成像技術的應用是推動市場成長的主要因素。

馬匹保健是獸醫學的一個分支，專注於馬匹疾病的診斷、治療和預防。這包括使用各種產品，例如疫苗、驅蟲藥、外用藥物、關節補充劑、益生元、驅蠅噴霧劑、蹄部護理劑、消毒劑和性能增強劑。馬匹保健涵蓋預防保健、疾病管理、跛行治療、繁殖保健、口腔衛生、復健和行為問題處理。這有助於改善馬匹的整體健康狀況，預防未來併發症，早期發現疾病，提高繁殖成功率，延長壽命，並降低跛行、牙科疾病、感染疾病、肥胖、皰疹和狂犬病等嚴重的風險。

馬匹保健市場的發展趨勢：

由於賽馬、農業和伴侶動物等領域的廣泛應用，馬匹數量激增，這是推動市場成長的主要因素之一。馬匹保健服務和產品，例如預防醫學、繁殖服務、復健中心、疫苗和保健品，被廣泛用於確保馬匹的最佳表現、預防併發症、保護馬匹免受傷害並降低患病風險。此外，馬主對馬匹健康和合理營養重要性的認知不斷提高，也是推動市場成長的另一個因素。同時，政府為支持動物福利、促進負責任的繁殖以及提供高品質醫療保健設施而實施的各項政策，也對市場成長產生了積極影響。此外，數位X光、超音波和內視鏡等先進成像技術的應用，能夠提供馬匹身體的詳細截面影像，從而診斷肌肉骨骼損傷、跛行和內臟疾病，這也促進了市場成長。此外，近年來馬匹穿戴式健康監測設備的興起，使得馬匹能夠持續監測生命徵象、活動量和行為，從而及早發現健康問題，這推動了市場成長。同時，賽馬、場地障礙賽、盛裝馬場馬術和耐力賽等馬術比賽的日益增加也促進了市場成長。預計其他推動市場成長的因素還包括消費者購買力的提升、寵物「擬人化」趨勢的興起、積極的研發活動以及電子商務產業的快速發展。

本報告解答的主要問題

  • 迄今為止，全球馬匹保健市場的發展趨勢是什麼？您預計未來幾年這些趨勢將如何演變？
  • 全球馬匹保健市場的促進因素、限制因素和機會是什麼？
  • 促進因素、阻礙因素和機會如何影響全球馬匹醫療保健市場？
  • 主要區域市場有哪些？
  • 哪個國家的馬匹醫療保健市場最具吸引力？
  • 以產品來看，市場區隔是如何計算的？
  • 馬匹保健市場中最具吸引力的產品是什麼？
  • 按適應症分類的市場組成是什麼？
  • 馬匹保健市場中最具吸引力的適應症是什麼？
  • 按分銷管道分類的市場區隔如何？
  • 在馬匹保健市場中，最具吸引力的通路是什麼？
  • 全球馬匹保健市場的競爭格局如何？
  • 全球馬匹保健市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球馬匹保健市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 製藥
    • 主要部分
      • 抗發炎藥
      • 寄生蟲控制藥物
      • 其他
  • 疫苗
    • 主要部分
      • 活病毒疫苗
      • 重組疫苗
      • 其他
  • 藥用飼料添加劑
  • 診斷
  • 其他

第7章 市場區隔：依適應症分類

  • 肌肉骨骼疾病
  • 寄生蟲控制
  • 馬皰疹病毒
  • 馬腦脊髓炎
  • 馬流感
  • 西尼羅病毒
  • 破傷風
  • 狂犬病
  • 其他

第8章 市場區隔：依分銷通路分類

  • 獸醫醫院和診所
  • 零售藥局和藥房

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章：促進、抑制與機遇

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Boehringer Ingelheim International GmbH
    • Ceva
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Esaote SpA
    • Hallmarq Veterinary Imaging
    • IDEXX Laboratories Inc.
    • Merck & Co. Inc.
    • Vetoquinol SA
    • Zoetis Inc
Product Code: SR112026A7779

The global equine healthcare market size reached USD 1.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 5.10% during 2026-2034. The rapid increase in the equine population, rising awareness among owners regarding equine health and proper nutrition, and the utilization of advanced imaging techniques represent some of the key factors driving the market.

Equine healthcare is a branch of veterinary medicine that focuses on the diagnosis, treatment, and prevention of diseases in horses. It involves the utilization of various products, such as vaccines, dewormers, topical treatments, joint supplements, prebiotics, fly sprays, hoof conditioners, antiseptics, and performance additives. Equine healthcare includes preventive care, illness management, lameness treatment, reproductive care, oral hygiene, rehabilitation, and addressing behavioral issues. It assists in improving overall health, preventing future complications, allowing early disease detection, facilitating successful breeding, promoting a longer lifespan, and reducing the risk of serious diseases, such as lameness, dental problems, infections, obesity, herpes, and rabies.

EQUINE HEALTHCARE MARKET TRENDS:

The rapid increase in the equine population due to the widespread utilization of horses in racing, farming, and as companions is one of the primary factors propelling the market growth. Equine healthcare services and products, such as preventive care, reproductive services, rehabilitation centers, vaccines, and health supplements, are widely used to ensure optimum performance, prevent complications, protect from injuries, and reduce the risk of illnesses. In addition to this, rising awareness among the owners regarding the importance of equine health and proper nutrition is acting as another growth-inducing factor. Furthermore, the implementation of various government initiatives to support animal welfare, promote responsible ownership, and provide access to high-quality healthcare facilities is positively influencing the market growth. Additionally, the utilization of advanced imaging techniques, such as digital radiography, ultrasound, and endoscopy, to provide detailed cross-sectional images of the horse's body, thus allowing the diagnosis of musculoskeletal injuries, lameness, and internal diseases, is contributing to the market growth. Besides this, the recent development of wearable health monitoring devices for horses, which allows continuous monitoring of vital signs, activity levels, and behavior to facilitate early detection of any health issues, is providing an impetus to the market growth. Moreover, the growing number of equine sports, such as racing, jumping, dressage, and endurance riding, is propelling the market growth. Other factors, including rising expenditure capacities of consumers, emerging trends of pet humanization, extensive research and development (R&D) activities, and rapid expansion of the e-commerce industry, are anticipated to drive the market growth.

KEY MARKET SEGMENTATION:

Product Insights:

  • Drugs
    • Anti-Inflammatory Drugs
    • Parasiticide Drugs
    • Others
  • Vaccines
    • Live Attenuated Vaccine
    • Recombinant Vaccine
    • Others
  • Medicated Feed Additives
  • Diagnostics

Indication Insights:

  • Musculoskeletal Disorders
  • Parasite Control
  • Equine Herpes Virus
  • Equine Encephalomyelitis
  • Equine Influenza
  • West Nile Virus
  • Tetanus
  • Rabies

Distribution Channel Insights:

  • Veterinary Hospitals and Clinics
  • Retail Pharmacies and Drug Stores

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for equine healthcare. Some of the factors driving the North America equine healthcare market included the rising equine population, supportive government policies, and significant technological advancements.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global equine healthcare market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Esaote SpA, Hallmarq Veterinary Imaging, IDEXX Laboratories Inc., Merck & Co. Inc., Vetoquinol S.A., Zoetis Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global equine healthcare market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global equine healthcare market?
  • What is the impact of each driver, restraint, and opportunity on the global equine healthcare market?
  • What are the key regional markets?
  • Which countries represent the most attractive equine healthcare market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the equine healthcare market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the equine healthcare market?
  • What is the breakup of the market based on distribution channel?
  • Which is the most attractive distribution channel in the equine healthcare market?
  • What is the competitive structure of the global equine healthcare market?
  • Who are the key players/companies in the global equine healthcare market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Equine Healthcare Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Anti-Inflammatory Drugs
      • 6.1.2.2 Parasiticide Drugs
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Live Attenuated Vaccine
      • 6.2.2.2 Recombinant Vaccine
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Medicated Feed Additives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Diagnostics
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Musculoskeletal Disorders
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parasite Control
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Equine Herpes Virus
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Equine Encephalomyelitis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Equine Influenza
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 West Nile Virus
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Tetanus
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Rabies
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Others
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Veterinary Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim International GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Ceva
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Dechra Pharmaceuticals PLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Elanco Animal Health Incorporated
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Esaote SpA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Hallmarq Veterinary Imaging
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 IDEXX Laboratories Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck & Co. Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Vetoquinol S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Zoetis Inc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Equine Healthcare Market: Major Drivers and Challenges
  • Figure 2: Global: Equine Healthcare Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Equine Healthcare Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Equine Healthcare Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Equine Healthcare Market: Breakup by Indication (in %), 2025
  • Figure 6: Global: Equine Healthcare Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Equine Healthcare Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Equine Healthcare (Drugs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Equine Healthcare (Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Equine Healthcare (Vaccines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Equine Healthcare (Vaccines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Equine Healthcare (Medicated Feed Additives) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Equine Healthcare (Medicated Feed Additives) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Equine Healthcare (Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Equine Healthcare (Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Equine Healthcare (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Equine Healthcare (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Equine Healthcare (Musculoskeletal Disorders) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Equine Healthcare (Musculoskeletal Disorders) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Equine Healthcare (Parasite Control) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Equine Healthcare (Parasite Control) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Equine Healthcare (Equine Herpes Virus) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Equine Healthcare (Equine Herpes Virus) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Equine Healthcare (Equine Encephalomyelitis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Equine Healthcare (Equine Encephalomyelitis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Equine Healthcare (Equine Influenza) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Equine Healthcare (Equine Influenza) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Equine Healthcare (West Nile Virus) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Equine Healthcare (West Nile Virus) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Equine Healthcare (Tetanus) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Equine Healthcare (Tetanus) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Equine Healthcare (Rabies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Equine Healthcare (Rabies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Equine Healthcare (Other Indications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Equine Healthcare (Other Indications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Equine Healthcare (Veterinary Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Equine Healthcare (Veterinary Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Equine Healthcare (Retail Pharmacies and Drug Stores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Equine Healthcare (Retail Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: North America: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: North America: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: United States: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: United States: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Canada: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Canada: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Asia-Pacific: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Asia-Pacific: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: China: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: China: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Japan: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Japan: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: India: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: India: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: South Korea: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: South Korea: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Australia: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Australia: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Indonesia: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Indonesia: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Europe: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Europe: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Germany: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Germany: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: France: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: France: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: United Kingdom: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: United Kingdom: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Italy: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Italy: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Spain: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Spain: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Russia: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Russia: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Latin America: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Latin America: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Brazil: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Brazil: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Mexico: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Mexico: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Others: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Others: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Middle East and Africa: Equine Healthcare Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Middle East and Africa: Equine Healthcare Market: Breakup by Country (in %), 2025
  • Figure 88: Middle East and Africa: Equine Healthcare Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Global: Equine Healthcare Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Equine Healthcare Industry: Value Chain Analysis
  • Figure 91: Global: Equine Healthcare Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Equine Healthcare Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Equine Healthcare Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Equine Healthcare Market Forecast: Breakup by Indication (in Million USD), 2026-2034
  • Table 4: Global: Equine Healthcare Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: Equine Healthcare Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Equine Healthcare Market: Competitive Structure
  • Table 7: Global: Equine Healthcare Market: Key Players